Newsletter | July 5, 2022

07.05.22 -- What Can You Do To Improve Your ADC's Chance Of Clinical Success?

 
New Podcast Episode
Industry Insights
What Can You Do To Improve Your ADC’s Chance Of Clinical Success?

Improving your ADC’s chance of clinical success requires an understanding of what potential obstacles lie ahead and what capabilities and expertise are necessary to overcome them.

Effects Of The Ongoing Pandemic On Bupivacaine HCI Supply

Throughout the pandemic, painkiller and sedative demands have spiked. Drug manufacturers and CDMOs have become critical in efforts to stabilize the supply of Bupivacaine HCl and other essential drugs.

High-Throughput Characterization Of RNA

Here we demonstrate how a multicapillary capillary electrophoresis (CE) system is used to efficiently separate a wide range of RNA-based molecules by size and demonstrates the multiplex capability for RNA characterization.

mAbs Biotech Recognizes Value In Expertise, Track Record

See how reputation for quality and experience with antibodies were driving forces in the CDMO selection for a CPI-006 antibody program.

Pediatric Dosage Formulation

A biopharmaceutical company known for its successful anti-infective products for adults sought to reformulate the product into an age-appropriate dosage form for young children and preteen patients.

The Critical Steps For Protein Therapeutic Potency Assay Development

Learn from an expert about the process of assay development, qualification, and validation for potency assays and how we can support customers through this vital step.

How To Deal With The Complexity Of Drugs In Clinical Development

Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.

Most Popular News
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.